QSPTMDD

Target-Gated Cargo QSP

Mechanistic QSP model for an intravenously dosed biologic designed to remain closed systemically and open after engaging a tumor-enriched gate. It connects three-compartment disposition, reversible cargo accessibility, tumor retention, and central-versus-tumor receptor occupancy using transparent UBI-authored equations and synthetic exploratory assumptions.

Therapeutic
generic target-gated cargo
Target
configurable tumor gate target, configurable cargo receptor
Disease
Solid tumors with an accessible tumor-enriched gate target
Model type
QSP, TMDD

Complete model workspace

The public explorer presents a concise set of curated controls and readouts. Sign in to edit every declared parameter and run the complete released model.

Parameters
21
States
11
Equations
11
Derived outputs
19

Explore this model

Choose a starting point to view its result. Adjust key model inputs when you want to explore a different outcome.

Balanced gate, 30 nmol IV

Nominal synthetic probe intended to produce low-to-moderate systemic cargo-receptor occupancy and substantially higher tumor occupancy.

Starting result

This result reflects the starting settings. Run your changes to update it.

Result preview could not load

The generated result could not be loaded. The inputs remain available below.

Starting configuration

Time: 0–336 hour; step 6

InputDefaultAvailable range
Background opening rate0.004 1/h0.002–0.006 1/h
Accessible tumor gate target capacity0.15 nmol0.075–0.225 nmol
Open construct gate dissociation0.03 1/h0.015–0.045 1/h
Cargo receptor association0.4 1/(nM*h)0.2–0.6 1/(nM*h)
Central tumor exchange clearance2.00e-5 L/h1.00e-5–3.00e-5 L/h

Expected readouts

Systemic cargo receptor occupancy (%) · Tumor cargo receptor occupancy (%) · Tumor gate target occupancy (%) · Total modeled construct (nmol)

Adjustable model parameters

This public explorer exposes 5 curated parameters. Sign in to edit all 21 declared model parameters.

More key parameters (1)

How the model represents the biology

Explores how systemic closure, tumor-gate abundance and affinity, gate-assisted opening, tumor retention, cargo-receptor affinity, and dose combine to create a local-versus-systemic receptor-occupancy window.

An 11-state, three-compartment model follows closed and open construct in central plasma, peripheral tissue, and tumor. Central open construct can bind a finite cargo-receptor capacity. In tumor, free closed or open construct can bind a finite gate capacity; gate-bound construct switches between closed and open states, and open free or gate-retained construct can engage tumor cargo receptor. The main outputs are central and tumor construct concentrations, receptor occupancy, and tumor gate occupancy.

Research use only — not for patient-specific prediction or dosing advice.

Ubi Biologics